top of page

Search Results

Results found for "custom ligand development"

  • Beyond Clearance: The Strategic Power of Irreversible Drug Binding

    They’re kinetic game-changers —compounds that rewrite the relationship between ligand , receptor , and Getting this wrong doesn’t just slow a program—it can mislead the entire development strategy . Direct input  on future sessions—so topics match the hurdles your team faces in discovery and development

  • 📰 GPCR Weekly News, April 22 to 28, 2024

    Hoare's workshop for individuals who live and work in developing countries.  We define a developing country based on World Bank Classifications for its 2024 fiscal year. Protein-Coupled Receptor Inflammatory Signaling at the Endosome GPCR Binders, Drugs, and more Discovery and development GPCR Research Single-chain fluorescent integrators for mapping G-protein-coupled receptor agonists Development of a synthetic relaxin-3/INSL5 chimeric peptide ligand for NanoBiT complementation binding assays Generation

  • The Perils and Guardrails of Modifying Signalling Proteins in Bioassays

    Why 90% of clinical drug development fails and how to improve it? Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018. How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment. Clinical development times for innovative drugs. Drug discovery and development: Role of basic biological research.

  • 📰 GPCR Weekly News, May 8 to 14, 2023

    GPCR Activation and Signaling Ligand-induced activation and G protein coupling of prostaglandin F2α receptor presented at the 23rd BioEquity Conference British Patient Capital Invests £10m in next-generation drug development Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. Antibody Engineering Scientist—Immuno-Oncology Convergent Research - Senior Scientist, Cell-Based Assay Development

  • Asking Better Questions in Science: A Practical Guide for Emerging Researchers

    In his collaboration with David Hodson, every major leap—from early ligand design to GPCR visualization

  • 📰 GPCR Weekly News, January 16 to 22, 2023

    Ligands selectively tune the local and global motions of neurotensin receptor 1 (NTS1). Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

  • 📰 GPCR Weekly News, June 17 to 23, 2024

    Stay informed about the most recent developments in GPCR research and industry updates. Rhipicephalus microplus) kinin receptor identifies small molecules that inhibit midgut contractions Ligand-based of phytosterols and triterpenes isolated from Cryptostegia grandiflora against Candida auris FKBP12 Development and reprograms fungal cells for nematode hunting Role and recent progress of P2Y12 receptor in cancer development

  • 📢 GPCR Update: August 19-25, 2024 | Thrilling Announcement: New Pharmacology Course Dates & Exclusive Discounts Inside!

    GPCR Activation and Signaling Homodimerization of CB2 cannabinoid receptor triggered by a bivalent ligand

  • 📰 GPCR Weekly News, April 24 to 30, 2023

    Conformationally Selective 2-Aminotetralin Ligands Targeting the alpha2A- and alpha2C-Adrenergic Receptors Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. Antibody Engineering Scientist—Immuno-Oncology Convergent Research - Senior Scientist, Cell-Based Assay Development

  • 📰 GPCR Weekly News, March 20 to 26, 2023

    A snake toxin as a theranostic agent for the type 2 vasopressin receptor Small-Molecule Fluorescent Ligands Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

  • Irreversible Drugs, Real Control: Design for Durable Target Engagement

    Value at a glance: From screens to hits —how to identify novel GPCR ligands with structure-based workflows

  • 📰 GPCR Weekly News

    Ligand recognition and activation of neuromedin U receptor 2. Drugs, and more Engineered Human Antibody with Improved Endothelin Receptor Type A Binding Affinity, Developability BioSpace Sosei Heptares Notes its Partner Tempero Bio has Received FDA Clearance to Advance Clinical Development Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

  • 📰 GPCR Weekly News, July 1 to 7, 2024

    Sequential Injections of Pure and Mixed Sweeteners GPCRs involved in metabolic diseases: pharmacotherapeutic development Research Computational modelling of dynamic cAMP responses to GPCR agonists for exploration of GLP-1R ligand

  • Constitutive, Basal, and β-Alanine-Mediated Activation of the Human Mas-Related G Protein-Coupled ..

    Additionally, we investigated the constitutive (ligand-independent) and basal activity of MRGPRD and

  • Lysophosphatidic Acid and Several Neurotransmitters Converge on Rho-Kinase 2 Signaling to Manage...

    Furthermore, ROCK activity assays were performed to evaluate the ability of various physiological GPCR ligands

  • 📰 GPCR Weekly News, March 18 to 24, 2024

    3 Pathfndr-2 Study In Acromegaly Patients GPCR Events, Meetings, and Webinars March 24 - 29, 2024 | Ligand

  • Adhesion GPCR Consortium Newsletter - May 2024

    To my surprise and delight, the neurexins happened to be ligands for one isoform of the Latrophilins. understand how aGPCR works but might also provide a guide to how pharmacological approaches will be developed among the aGPCR community, added to the fact that this will all take place for the first time in a developing

  • Understanding Enzyme Inhibition In GPCR Discovery Programs

    Whether you’re designing a ligand, optimizing ADME, or predicting PK, enzyme inhibition defines what

  • 📰 GPCR Weekly News, June 24 to 30, 2024

    Basis of MC1R Activation: Mutation-Induced Alterations in Structural Dynamics Structural insights into ligand

  • Why Kinetics Matter More Than Kd in GPCR Drug Discovery

    Identify emerging targets:  Allosteric modulators, biased ligands, and kinetic frameworks will dominate

  • An overview of the compartmentalized GPCR Signaling: Relevance and Implications

    signaling, GPCRs are also known to localize to the Golgi apparatus, where they can be activated by ligands specific intracellular compartments and signaling pathways associated with GPCRs holds promise for the development For example, the nuclear envelope presents a barrier that restricts the passage of large molecules, making This may involve the development of specialized delivery vehicles, such as nanoparticles or liposomes

  • ⛵Sailing the GPCR Seas: Your Weekly Research Voyage! ⦿ Nov 11 - 17, 2024

    Drugs, and more Kinetic Basis for the Design of Azobenzene-Based Photoswitchable A2a Adenosine Receptor Ligands

  • Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation

    The cellular membrane's composition, organization, and physical properties might impact ligand binding

  • Understanding Orthosteric Binding: The Key to Drug Action

    Understanding this process is crucial for anyone interested in drug development and action. This foundational knowledge guides researchers in the development of new therapeutics. Implications for Drug Development As drug developers, understanding these nuances can significantly impact This understanding can enhance your appreciation for drug development and therapeutic action.

  • Ode to GPCRs

    discoveries of important principles for drug treatment.[24–30] Black was particularly interested in developing Our understanding of how various factors, such as lipid composition, osmotic stress, and allosteric ligands

  • Lab Leadership Without Ego: How Sokhom Pin Built the Happiest Team at Alkermes

    When Sokhom joined Alkermes, the company had a strong development arm, but a relatively underdeveloped with building an in vitro pharmacology group from scratch , including infrastructure, hiring, assay development

  • FDA Approval Is a Strategy Obstacle, Not a Paperwork Problem

    And if your development plan was designed to persuade , not to withstand pressure , then you are not to demonstrate confidence, the FDA is systematically looking for structural weak points  across your development your plan shows signs of future collapse . 👉 When they spot a mismatch between your data and your development Reverse Engineering Your Path to FDA Approval Most biotech development plans are built forward : start This is the principle of strategic reverse engineering . 👉 It means designing your development path

  • Building Backwards: Why Top-Down Models Could Revolutionize Pain Research

    This approach reflects his focus on developing models that behave  like patients before molecular exploration "I'm particularly interested in model development... seeing if we can bring preclinical models much closer

  • Pharmacologic Models

    Probability Models   This is practical drug development expertise from Terry’s 40+ years of experience

  • APEX2/AUR Biosensor: A Powerful Tool for Protein Interaction and Trafficking

    The development of molecular tools to study GPCR trafficking in real-time opens new avenues for understanding opioid crisis continues to challenge public health, insights gained from this research could inform the development beyond basic science ; understanding the role of DNAJC13 in GPCR trafficking could profoundly affect the development

bottom of page